(OTLK) Outlook Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Outlook Therapeutics | (OTLK) share price targets
Complete technical analysis of Outlook Therapeutics (OTLK) by charts plus indicators, forecast predictions and share price targets for Outlook Therapeutics (OTLK)
Outlook Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-16 View latest technical analysis
10 day averaged volume of Outlook Therapeutics is 284704
Date | Daily Closing Price | Open | High | Low | Volume |
16 Mon Sep 2024 | 5.93 | 6.57 | 6.67 | 5.88 | 1.312 times |
13 Fri Sep 2024 | 6.47 | 6.58 | 6.80 | 6.35 | 1.338 times |
12 Thu Sep 2024 | 6.49 | 7.03 | 7.26 | 6.45 | 1.58 times |
11 Wed Sep 2024 | 7.03 | 7.77 | 7.85 | 6.94 | 1.745 times |
10 Tue Sep 2024 | 7.79 | 8.04 | 8.24 | 7.66 | 0.898 times |
09 Mon Sep 2024 | 8.01 | 7.96 | 8.32 | 7.95 | 0.65 times |
06 Fri Sep 2024 | 7.95 | 7.82 | 8.05 | 7.63 | 0.53 times |
05 Thu Sep 2024 | 7.82 | 7.35 | 7.89 | 7.20 | 0.535 times |
04 Wed Sep 2024 | 7.36 | 6.81 | 7.49 | 6.80 | 1.168 times |
03 Tue Sep 2024 | 6.74 | 7.28 | 7.45 | 6.61 | 1.207 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 6.1, for a target of 6.8 or 7.27
Share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Target | 5.88 |
Upside Target | 6.35 |
Upside Target | 6.61 |
Upside Target | 7.23 |
Upside Target | 7.53 |
Upside Target | 7.83 |
Upside Target | 8.00 |
Upside Target | 8.05 |
Upside Target | 8.09 |
Upside Target | 8.32 |
Upside Target | 9.12 |
Upside Target | 9.25 |
Intraday share price targets for Outlook Therapeutics (OTLK)
Target Type | Value |
Downside Intraday Target | 5.65 |
Downside Intraday Target | 5.37 |
Upside Intraday Target | 6.44 |
Upside Intraday Target | 6.95 |
Upside Intraday Target | 6.16 |
Weekly technical analysis of Outlook Therapeutics (OTLK)
Date | Weekly Closing Price | Open | High | Low | Volume |
16 Mon Sep 2024 | 5.93 | 6.57 | 6.67 | 5.88 | 0.211 times |
13 Fri Sep 2024 | 6.47 | 7.96 | 8.32 | 6.35 | 1.805 times |
06 Fri Sep 2024 | 7.95 | 7.28 | 8.05 | 6.61 | 9.893 times |
30 Fri Aug 2024 | 7.35 | 7.34 | 7.53 | 7.23 | 0.212 times |
30 Fri Aug 2024 | 7.35 | 7.50 | 7.83 | 7.23 | 0.547 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Outlook Therapeutics (OTLK)
Date | Monthly Closing Price | Open | High | Low | Volume |
16 Mon Sep 2024 | 5.93 | 7.28 | 8.32 | 5.88 | 0.935 times |
30 Fri Aug 2024 | 7.35 | 7.75 | 8.09 | 6.90 | 0.75 times |
31 Wed Jul 2024 | 7.75 | 7.37 | 9.25 | 6.93 | 0.924 times |
28 Fri Jun 2024 | 7.38 | 7.07 | 8.00 | 6.65 | 0.835 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Outlook Therapeutics (OTLK)
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Outlook Therapeutics in short term and the sell signal is strong.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.96 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Outlook Therapeutics in short term and the sell signal is strong.
Outlook Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Outlook Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.96 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.